SCHEMBL10076823

SCHEMBL10076823

COc1ccc(B2OCc3cc(F)ccc32)c(OC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
PDE3A Q14432 1/20 0.47
PDE4A P27815 3/20 0.43
PDE4B Q07343 3/20 0.43
PDE4C Q08493 3/20 0.43
PDE4D Q08499 3/20 0.43
CA12 O43570 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
CYP3A4 P08684 2/20 0.37
ALDH1A1 P00352 1/20 0.37
NFE2L2 Q16236 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
HTR2B P41595 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10053155 0.91 CA1 (0.46) CA1CA2PDE3APDE4APDE4B
SCHEMBL10053150 0.86 CA1 (0.47) CA1CA2PDE3APDE4APDE4B
SCHEMBL10053143 0.86 CA1 (0.49) CA1CA2PDE3APDE4APDE4B
SCHEMBL10053165 0.85 CA1 (0.50) CA1CA2PDE3APDE4APDE4B
SCHEMBL10053159 0.83 CA1 (0.49) CA1CA2PDE3APDE4APDE4B
SCHEMBL10053148 0.80 CA1 (0.46) CA1CA2PDE3APDE4APDE4B
SCHEMBL10053167 0.78 CA1 (0.47) CA1CA2PDE3APDE4APDE4B
SCHEMBL10053142 0.77 CA1 (0.46) CA1CA2PDE3APDE4APDE4B
SCHEMBL10053270 0.76 CA1 (0.44) CA1CA2PDE3APDE4APDE4B
SCHEMBL10053273 0.74 CA1 (0.54) CA1CA2PDE3APDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106031-B2 Hydrolytically-resistant boron-containing therapeutics and methods of use ANACOR PHARMACEUTICALS, INC. (US) 2012-01-31 US disclosed
WO-2007131072-A2 HYDROLYTICALLY-RESISTANT BORON-CONTAINING THERAPEUTICS AND METHODS OF USE ANACOR PHARMACEUTICALS, INC. (US) 2007-11-15 WO disclosed